ReviewFrontiers in immunology2026

Dual PD-1 and CTLA-4 targeting in endometrial carcinoma: integrating efficacy, toxicity, and biomarkers into clinical practice.

Lan Zhong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.